Tag Archives: Biocell

FDA Survey to Determine How Women Weigh Breast Implant Cancer Risks

June 16, 2022 By: Russell Maas

The survey was designed and sent out after an Allergan textured breast implant recall due to the risk of breast implant associated ALCL
Biocell Breast Implant Lawsuits Allowed To Proceed After Allergan Attempt To Dismiss Claims Rejected

March 25, 2021 By: Irvin Jackson
Most Breast Implant ALCL Cases Resolved Through Breast Implant Removal: Study

February 15, 2021 By: Irvin Jackson
Biocell Breast Implant Lawsuit Calls For Manufacturer To Pay For Removal After Recall

October 15, 2020 By: Irvin Jackson
Woman Files Allergan Breast Implant Lawsuit After Developing Symptoms Of BIA-ALCL

September 18, 2020 By: Irvin Jackson
Allergan Misled FDA With “Junk Science”, According To Breast Implant Lymphoma Lawsuit

June 08, 2020 By: Irvin Jackson
Breast Implant Wrongful Death Lawsuit Filed Over Cancer From Allergan Biocell Design

February 04, 2020 By: Irvin Jackson
McGhan Breast Implant Lawsuit Filed Over Lymphoma Caused By Textured Design

January 22, 2020 By: Irvin Jackson
Breast Implant Lymphoma Risk From Allergan Biocell Known By Manufacturer Since 2011: Lawsuit

December 23, 2019 By: Irvin Jackson
Breast Implant Lymphoma Diagnosis Blamed on Allergan Biocell Design, Lawsuit Claims

December 05, 2019 By: Irvin Jackson

Cartiva Recall Lawsuit Alleges Failed Toe Implant Had To Be Surgically Removed Days Before Manufacturer Acknowledged Defect (Posted 4 days ago)

Although there were reports of problems with Cartiva implants for years, a recently filed lawsuit alleges the manufacturer delayed issuing a recall until October 2024.

MDL Judge Schedules Ozempic Lawsuit Status Conferences Throughout 2025 (Posted 5 days ago)

With the first Ozempic lawsuit bellwether trials not expected to begin until at least late 2026 or early 2027, the court will address motions to dismiss and other “cross cutting” issues in 2025.

Valsartan Bellwether Lawsuit Over Cancer Caused by Recalled Blood Pressure Drug Set for September 8, 2025 (Posted 6 days ago)

The first Valsartan bellwether trial will begin on September 8, 2025, involving allegations that the generic hypertension drug contained toxic chemicals that resulted in a liver cancer diagnosis.

Tag Archives: Biocell

FDA Survey to Determine How Women Weigh Breast Implant Cancer Risks

Biocell Breast Implant Lawsuits Allowed To Proceed After Allergan Attempt To Dismiss Claims Rejected

Most Breast Implant ALCL Cases Resolved Through Breast Implant Removal: Study

Biocell Breast Implant Lawsuit Calls For Manufacturer To Pay For Removal After Recall

Woman Files Allergan Breast Implant Lawsuit After Developing Symptoms Of BIA-ALCL

Allergan Misled FDA With “Junk Science”, According To Breast Implant Lymphoma Lawsuit

Breast Implant Wrongful Death Lawsuit Filed Over Cancer From Allergan Biocell Design

McGhan Breast Implant Lawsuit Filed Over Lymphoma Caused By Textured Design

Breast Implant Lymphoma Risk From Allergan Biocell Known By Manufacturer Since 2011: Lawsuit

Breast Implant Lymphoma Diagnosis Blamed on Allergan Biocell Design, Lawsuit Claims

More Top Stories

Review A Case